共 50 条
- [32] Once-daily low dose fluticasone propionate diskus as initial therapy in the treatment of adult subjects with persistent asthma - A subset analysis of the clinical efficacy of once-daily dosing in subjects with mild-to-moderate asthma JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S15 - S15
- [33] Highly Variable Pharmacokinetics of Once-Daily Intravenous Busulfan When Combined with Fludarabine in Pediatric Patients: Phase I Clinical Study for Determination of Optimal Once-Daily Busulfan Dose Using Pharmacokinetic Modeling BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (06) : 944 - 950
- [35] Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes Diabetes Therapy, 2015, 6 : 547 - 558
- [38] Test Dose Pharmacokinetics in Pediatric Patients Receiving Once-Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach? JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03): : 332 - 339
- [39] Once-daily versus twice-daily Lopinavir/Ritonavir in antiretroviral-naive HIV-positive patients: A 48-week randomized clinical trial JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (02): : 265 - 272
- [40] Treatment of advanced HIV disease in antiretroviral-naive HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2011, 23 (11): : 1500 - 1504